The Flu Biopharmaceutical Development (Flu-BPD) group is a multi-disciplinary scientific function providing expertise in Virology, Process Development, and Analytical Development. The team is responsible for the development of candidate vaccine virus strains for the seasonal, live attenuated, influenza vaccine (LAIV).The LAIV Virology Group is responsible and accountable for the generation and characterisation of candidate vaccine strains. In this role, you will work within the LAIV Strain Development team to help deliver the seasonal influenza vaccines strain(s). You will work primarily on the generation and characterisation of vaccine candidates, and will have opportunities to work on the other key processes involved in getting strains into manufacturing, as and when required. This is an ambitious, yet highly rewarding, lab-based role within a commercial setting, providing the rare opportunity to have a visible and direct impact on public health. 

Knowledge of GLP, in particular manufacturing and/or laboratory practices and quality systemsAbility to prioritise workload in order to work to tight timelines.

Interact with colleagues in Quality Control and Quality Assurance teams during the strain development season, to ensure smooth progression of candidates from the research environment, into the quality/manufacturing process stages.Contribute to team projects, and trouble-shooting ideas, as and when required.